Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T22:11:23.751Z Has data issue: false hasContentIssue false

Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study – CORRIGENDUM

Published online by Cambridge University Press:  11 October 2021

Abstract

Type
Corrigendum
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association

This article when published failed to include the full list of Dr Ana González-Pinto’s affiliations, which are as follows:

  • Hospital Universitario de Álava, Álava, Spain

  • CIBERSAM, Biomedical Research Centre in Mental Health Network, Madrid, Spain

  • Universidad del País Vasco, Álava, Spain

  • IIS Bioaraba, Álava, Spain

References

Olivares, JM, González-Pinto, A, Páramo, M, on behalf of the PROSIGO Study Group (2021). Predictors of persistence in patients with schizophrenia treated with aripiprazole once-monthly long-acting injection in the Spanish clinical practice: a retrospective, observational study. European Psychiatry, 64(1), e40, 113 https://doi.org/10.1192/j.eurpsy.2021.23CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.